Malaria Consortium

More than 250,000 at-risk children in #SouthSudan and #Cotedivoire will receive the new R21/Matrix-M #malariavaccine — a significant advancement in the fight against one of the world's deadliest diseases.💉 Developed by Serum Institute of India Pvt. Ltd. and University of Oxford, and subsidised by Gavi, the Vaccine Alliance, the vaccine has shown promising results in clinical trials, with over 75 percent efficacy. The campaigns mark an important step towards the World Health Organization's goal of reducing malaria cases by 90 percent by 2030. Read more in our latest news piece: https://brnw.ch/21wLvMB

Optimised vector #surveillance is the foundation for effective vector control, and key to helping reduce malaria transmission. 📅 From 12–15 August, join Dr Neil Lobo – Research Professor at University of Notre Dame – for a series of online training sessions where he examines best practices for effective vector surveillance. The course, in collaboration with the Asia Pacific Malaria Elimination Network (APMEN), covers topics ranging from the importance of entomological surveillance and current gaps, to managing #data effectively. 📊 🖥️ Register here: tiny.cc/APMENVSP

We were proud to take part in another productive meeting of the Malaria Chemoprevention Research and Policy Uptake Task Team (NPRPUT) on 8 and 9 July in #Nigeria. We met with partners including the Federal Ministry of Health, National Malaria Elimination Programme and Osun State Ministry of Health to present interim results from our PMC Effect study.   Perennial malaria chemoprevention (#PMC) can provide protection against malaria for children in areas with year-round malaria transmission.  We’re generating evidence needed to support the uptake of PMC into the national health policy, taking steps towards more impactful malaria control efforts. ❌🦟 

Using existing structures to deliver multiple health services can be an effective way to make #healthcare go further, achieving greater impact — such as how, in #Nigeria, we are supporting the use of seasonal malaria chemoprevention to co-deliver vitamin A supplementation to children. GiveWell's insightful blog looks at what it means to combine health programmes effectively. #SMC #GlobalHealth

The High Level Political Forum (#HLPF) on Sustainable Development Goals concludes today in #NewYork. This annual gathering brings together world leaders, policymakers, and stakeholders to review progress on the #2030Agenda for Sustainable Development and the 17 #SDGs. Sonia Enosse, our Country Technical Coordinator in #Mozambique, highlights the critical link between inequality and health outcomes. As we work towards achieving the SDGs by 2030, her words remind us that equitable access to healthcare is key to preventing diseases and saving lives. 👀 Stay tuned for our SDGs blog...

We're excited to have participated in the RBM Partnership to End Malaria's Surveillance, Monitoring and Evaluation Working Group Annual Meeting in Nairobi 🌍🦟 We joined experts from around the world to tackle key challenges in #malaria surveillance as we move from control to elimination. This inspired discussions on cross-border collaboration, data quality, and innovative strategies to #EndMalaria. Together, we're making strides towards a malaria-free future!

"At the halfway point to the #SDGs, the world is faced with multiple challenges to ensuring global health #equity and it is essential that governments around the world – including the UK – come together to meet their commitments and are re-energised to achieve SDG3 to ensure healthy lives for all."   Read Action for Global Health's recommendations for #GlobalHealth in the Bond UK briefing on the #G7Summit 

#Mozambique is one of six countries that contribute to more than half of all global #malaria cases. Effective #surveillance is crucial for monitoring the disease burden, identifying outbreaks, and making data-driven decisions to control and eliminate malaria. Without strong surveillance systems, Mozambique's efforts to combat malaria are severely hampered, potentially leading to continued high rates of malaria transmission and inadequate responses to outbreaks. Discover how our project with Bill & Melinda Gates Foundation, Clinton Health Access Initiative, Inc., Goodbye Malaria, CISM- Centro de Investigação em Saúde de Manhiça, Mozambique's Ministry of Health and the World Health Organization improved data quality, motivated 👩🏾⚕️ health workers, and strengthened outbreak response. Read the project report for insights that can shape the future of malaria control: https://lnkd.in/eKiTdQuE

🦟🦠 Breaking news: #Malaria and #COVID19 — A critical intersection Malaria Consortium's groundbreaking research explores the complex relationship between malaria and COVID-19 in Africa. With 249 million malaria cases globally in 2022, understanding this interaction is crucial for #PublicHealth. Key focus areas: ✅ Investigating malaria prevalence in COVID-19 patients ✅ Exploring long COVID in malaria-endemic regions ✅ Informing policy for better health outcomes. This study could reshape our approach to these overlapping health challenges. Want to know more about this vital research? Read the full article here: https://lnkd.in/e2jTuJng

A 2022 survey from World Health Organization revealed deficiencies in #arbovirus outbreak preparedness, surveillance and control across #Africa. As part of London School of Hygiene and Tropical Medicine, U. of London's RAFT project, we are hosting a series of four workshops to assess and improve arbovirus preparedness efforts in #BurkinaFaso, #CôtedIvoire, #Cameroon and #Tanzania. Through group discussions and field visits with stakeholders and partners including WHO and the U.S. President's Malaria Initiative, we're strengthening national action plans for controlling arboviral diseases.